A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer
• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The aver...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mahar, Alyson L. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation - Garrote, Pedro J. ELSEVIER, 2019, journal of the International Association for the Study of Lung Cancer, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:86 ; year:2014 ; number:2 ; pages:281-287 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.lungcan.2014.09.013 |
|---|
| Katalog-ID: |
ELV022501886 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV022501886 | ||
| 003 | DE-627 | ||
| 005 | 20230623164102.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2014.09.013 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014006000012.pica |
| 035 | |a (DE-627)ELV022501886 | ||
| 035 | |a (ELSEVIER)S0169-5002(14)00400-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 100 | 1 | |a Mahar, Alyson L. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. | ||
| 650 | 7 | |a Physician's Practice Patterns |2 Elsevier | |
| 650 | 7 | |a Chemotherapy |2 Elsevier | |
| 650 | 7 | |a Costs and Cost Analysis |2 Elsevier | |
| 650 | 7 | |a Adjuvant |2 Elsevier | |
| 650 | 7 | |a Resectable Lung Cancer |2 Elsevier | |
| 650 | 7 | |a Lung Neoplasms |2 Elsevier | |
| 700 | 1 | |a Coburn, Natalie G. |4 oth | |
| 700 | 1 | |a Johnson, Ana P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Garrote, Pedro J. ELSEVIER |t Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |d 2019 |d journal of the International Association for the Study of Lung Cancer |g Amsterdam [u.a.] |w (DE-627)ELV002331438 |
| 773 | 1 | 8 | |g volume:86 |g year:2014 |g number:2 |g pages:281-287 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lungcan.2014.09.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 86 |j 2014 |e 2 |h 281-287 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a l m al alm |
|---|---|
| matchkey_str |
maharalysonlcoburnnataliegjohnsonanap:2014----:ppltobsdtdoteeoretlztoadotomngnrsc |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1016/j.lungcan.2014.09.013 doi GBVA2014006000012.pica (DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Mahar, Alyson L. verfasserin aut A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier Coburn, Natalie G. oth Johnson, Ana P. oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:86 year:2014 number:2 pages:281-287 extent:7 https://doi.org/10.1016/j.lungcan.2014.09.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 86 2014 2 281-287 7 045F 610 |
| spelling |
10.1016/j.lungcan.2014.09.013 doi GBVA2014006000012.pica (DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Mahar, Alyson L. verfasserin aut A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier Coburn, Natalie G. oth Johnson, Ana P. oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:86 year:2014 number:2 pages:281-287 extent:7 https://doi.org/10.1016/j.lungcan.2014.09.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 86 2014 2 281-287 7 045F 610 |
| allfields_unstemmed |
10.1016/j.lungcan.2014.09.013 doi GBVA2014006000012.pica (DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Mahar, Alyson L. verfasserin aut A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier Coburn, Natalie G. oth Johnson, Ana P. oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:86 year:2014 number:2 pages:281-287 extent:7 https://doi.org/10.1016/j.lungcan.2014.09.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 86 2014 2 281-287 7 045F 610 |
| allfieldsGer |
10.1016/j.lungcan.2014.09.013 doi GBVA2014006000012.pica (DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Mahar, Alyson L. verfasserin aut A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier Coburn, Natalie G. oth Johnson, Ana P. oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:86 year:2014 number:2 pages:281-287 extent:7 https://doi.org/10.1016/j.lungcan.2014.09.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 86 2014 2 281-287 7 045F 610 |
| allfieldsSound |
10.1016/j.lungcan.2014.09.013 doi GBVA2014006000012.pica (DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Mahar, Alyson L. verfasserin aut A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier Coburn, Natalie G. oth Johnson, Ana P. oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:86 year:2014 number:2 pages:281-287 extent:7 https://doi.org/10.1016/j.lungcan.2014.09.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 86 2014 2 281-287 7 045F 610 |
| language |
English |
| source |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:86 year:2014 number:2 pages:281-287 extent:7 |
| sourceStr |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:86 year:2014 number:2 pages:281-287 extent:7 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Physician's Practice Patterns Chemotherapy Costs and Cost Analysis Adjuvant Resectable Lung Cancer Lung Neoplasms |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| authorswithroles_txt_mv |
Mahar, Alyson L. @@aut@@ Coburn, Natalie G. @@oth@@ Johnson, Ana P. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002331438 |
| dewey-sort |
3610 |
| id |
ELV022501886 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022501886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164102.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2014.09.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014006000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022501886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(14)00400-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mahar, Alyson L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Physician's Practice Patterns</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Costs and Cost Analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adjuvant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Resectable Lung Cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lung Neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coburn, Natalie G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Johnson, Ana P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:86</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:281-287</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2014.09.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">86</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">281-287</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Mahar, Alyson L. |
| spellingShingle |
Mahar, Alyson L. ddc 610 Elsevier Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| authorStr |
Mahar, Alyson L. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002331438 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms Elsevier |
| topic |
ddc 610 Elsevier Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms |
| topic_unstemmed |
ddc 610 Elsevier Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms |
| topic_browse |
ddc 610 Elsevier Physician's Practice Patterns Elsevier Chemotherapy Elsevier Costs and Cost Analysis Elsevier Adjuvant Elsevier Resectable Lung Cancer Elsevier Lung Neoplasms |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n g c ng ngc a p j ap apj |
| hierarchy_parent_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| hierarchy_parent_id |
ELV002331438 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002331438 |
| title |
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| ctrlnum |
(DE-627)ELV022501886 (ELSEVIER)S0169-5002(14)00400-0 |
| title_full |
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| author_sort |
Mahar, Alyson L. |
| journal |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| journalStr |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
281 |
| author_browse |
Mahar, Alyson L. |
| container_volume |
86 |
| physical |
7 |
| class |
610 610 DE-600 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Mahar, Alyson L. |
| doi_str_mv |
10.1016/j.lungcan.2014.09.013 |
| dewey-full |
610 |
| title_sort |
a population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| title_auth |
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| abstract |
• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. |
| abstractGer |
• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. |
| abstract_unstemmed |
• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
2 |
| title_short |
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer |
| url |
https://doi.org/10.1016/j.lungcan.2014.09.013 |
| remote_bool |
true |
| author2 |
Coburn, Natalie G. Johnson, Ana P. |
| author2Str |
Coburn, Natalie G. Johnson, Ana P. |
| ppnlink |
ELV002331438 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.lungcan.2014.09.013 |
| up_date |
2024-07-06T22:08:30.432Z |
| _version_ |
1803869183470993408 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022501886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164102.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2014.09.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014006000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022501886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(14)00400-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mahar, Alyson L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We investigate the costs of adjuvant chemotherapy in resectable non-small cell lung cancer patients. • We compare the costs to randomized controlled trial results in a phase IV study. • The average cost per patient treated with surgery and adjuvant chemotherapy was $37,860.88 (2012 US). • The average per patient costs closely reflects the costs of treatment estimated in the randomized controlled trial. • Geographic variation in per patient resource utilization and costs exists and may be a target to reduce system inefficiencies.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Physician's Practice Patterns</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Costs and Cost Analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adjuvant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Resectable Lung Cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lung Neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coburn, Natalie G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Johnson, Ana P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:86</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:281-287</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2014.09.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">86</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">281-287</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4009047 |